cphi worldwide

Variable-dose pen injector platform designed for simple use

By Jenni Spinner

- Last updated on GMT

(Image: Stevanato Group)
(Image: Stevanato Group)

Related tags Drug delivery Injectables Stevanato Group Medical devices CPhI Worldwide

Stevanato Group is showcasing its SG Alina disposable, variable-dose pen injector platform, available with customizable features, at CPhI Worldwide 2021.

Stevanato Group, a company offering a variety of drug delivery, containment, and diagnostic products to pharmaceutical clients, is showings its SG Alina pen injector platform at CPhI Worldwide, taking place in person November 9-11 in Milan. The product, designed to be user-friendly for patients, is a variable-doze pen injector platform compatible with various current therapeutic regimens, as well as innovator diabetes-care treatments.

Andrea Zambon, Stevanato Group’s corporate business development director, said the SG Alina product fits in with the company’s mission to offer clients a broad range of options and solutions.

"The growing demand for customized products, produced faster and more cost-effectively than ever before, means pharma companies are increasingly outsourcing activities to contract organizations​," Zambon said. "Our team is looking forward to highlighting the benefits of our full-service, integrated, flexible, and modular approach for pharma companies large and small worldwide​."

According to Stevanato Group, the product is intended to be aesthetic as well as functional; features an easy-to-dial mechanism, optimized injection force for patient comfort, and a readable display.

Additionally, clients reportedly can customize the SG Alina pen injector with several options. These include dosing and color selection, going to more complex industrial designs tailored to the specifications of a particular client.

Stevanato Group reports the company will share with attendees of CPhI Worldwide a glimpse at the integrated approach to supporting pharmaceutical customers along the drug development process. Their stated offerings include analytical services, drug containment solutions, automation, and assembly equipment and contract manufacturing.

 

CPhI Worldwide 2021 is a hybrid event; the in-person component (expected to host up to 30,000 industry professionals with 1,400 exhibitors) takes place November 9-11 in Milan, and the digital content will be available until November 19. Read here to register or to see a list of sessions, events, and other features.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Related suppliers

Follow us

Products

View more

Webinars